David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MIME
1776
DELISTED
Mimecast Limited
MIME
| $3.37M | ﹤0.01% |
81,720
+65,123
| +392% | +$2.65M |
|
1777
Cognex
CGNX
$10.1B
| $3.36M | ﹤0.01% |
75,377
-73,780
| -49% | -$3.49M |
|
|
SHYF
1778
DELISTED
The Shyft Group
SHYF
| $3.36M | ﹤0.01% |
222,506
-62,157
| -22% | -$1.01M |
|
1779
Ternium
TX
$10.8B
| $3.36M | ﹤0.01% |
96,408
-107,156
| -53% | -$4.01M |
|
|
LHCG
1780
DELISTED
LHC Group LLC
LHCG
| $3.36M | ﹤0.01% |
39,205
-19,478
| -33% | -$1.48M |
|
|
KTWO
1781
DELISTED
K2M Group Holdings, Inc
KTWO
| $3.35M | ﹤0.01% |
149,078
+457
| +0.3% | +$9.63K |
|
1782
MYR Group
MYRG
$4.61B
| $3.34M | ﹤0.01% |
94,239
+1,515
| +2% | +$53.6K |
|
1783
Cathay General Bancorp
CATY
$4.13B
| $3.33M | ﹤0.01% |
+82,372
| New | +$3.41M |
|
1784
Genworth Financial
GNW
$3.73B
| $3.33M | ﹤0.01% |
741,102
-641,547
| -46% | -$2.21M |
|
1785
MiMedx Group
MDXG
$633M
| $3.33M | ﹤0.01% |
+521,358
| New | +$3.71M |
|
1786
CALL
Acuity Brands
AYI
$10.2B
| $3.33M | ﹤0.01% |
+28,700
| New | +$3.5M |
|
1787
Western Alliance Bancorporation
WAL
$8.69B
| $3.32M | ﹤0.01% |
58,701
+48,032
| +450% | +$2.88M |
|
|
BITA
1788
PUT
DELISTED
Bitauto Holdings Limited
BITA
| $3.32M | ﹤0.01% |
139,700
+20,200
| +17% | +$459K |
|
1789
PUT
Ligand Pharmaceuticals
LGND
$5.62B
| $3.31M | ﹤0.01% |
25,648
+9,618
| +60% | +$1.07M |
|
|
UCB
1790
United Community Banks
UCB
$4.23B
| $3.31M | ﹤0.01% |
108,065
+22,892
| +27% | +$745K |
|
|
WFT
1791
PUT
DELISTED
Weatherford International plc
WFT
| $3.31M | ﹤0.01% |
1,006,000
-14,200
| -1% | -$44.2K |
|
|
KEM
1792
DELISTED
KEMET Corporation
KEM
| $3.31M | ﹤0.01% |
137,002
+87,431
| +176% | +$1.78M |
|
1793
Northrop Grumman
NOC
$77.1B
| $3.3M | ﹤0.01% |
10,712
+6,505
| +155% | +$2.15M |
|
|
EGIO
1794
DELISTED
Edgio, Inc. Common Stock
EGIO
| $3.29M | ﹤0.01% |
18,406
-158
| -0.9% | -$30.6K |
|
1795
CALL
Equifax
EFX
$22.5B
| $3.29M | ﹤0.01% |
26,300
+9,100
| +53% | +$1.08M |
|
|
MMDM
1796
DELISTED
Modern Media Acquisition Corp. Common Stock
MMDM
| $3.29M | ﹤0.01% |
329,800
| – | – |
|
1797
Thermo Fisher Scientific
TMO
$232B
| $3.28M | ﹤0.01% |
15,847
+9,293
| +142% | +$1.97M |
|
1798
CALL
Expedia Group
EXPE
$40.6B
| $3.28M | ﹤0.01% |
27,300
+19,900
| +269% | +$2.3M |
|
1799
Allegiant Air
ALGT
$2.25B
| $3.28M | ﹤0.01% |
23,607
+14,294
| +153% | +$2.21M |
|
|
EPAY
1800
DELISTED
Bottomline Technologies Inc
EPAY
| $3.28M | ﹤0.01% |
65,817
+11,725
| +22% | +$523K |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.